Literature DB >> 30272088

Increased Mortality Despite Successful Multifactorial Cardiovascular Risk Reduction in Healthy Men: 40-Year Follow-Up of the Helsinki Businessmen Study Intervention Trial.

T E Strandberg1, K Räikkönen, V Salomaa, A Strandberg, H Kautiainen, M Kivimäki, K Pitkälä, J Huttunen.   

Abstract

OBJECTIVES: In a 5-year multifactorial risk reduction intervention for healthy men with at least one cardiovascular disease (CVD) risk factor, mortality was unexpectedly higher in the intervention than the control group during the first 15-year follow-up. In order to find explanations for the adverse outcome, we have extended mortality follow-up and examined in greater detail baseline characteristics that contributed to total mortality.
DESIGN: Long-term follow-up of a controlled intervention trial.
SETTING: The Helsinki Businessmen Study Intervention Trial. PARTICIPANTS AND INTERVENTION: The prevention trial between 1974-1980 included 1,222 initially healthy men (born 1919-1934) at high CVD risk, who were randomly allocated into intervention (n=612) and control groups (n=610). The 5-year multifactorial intervention consisted of personal health education and contemporary drug treatments for dyslipidemia and hypertension. In the present analysis we used previously unpublished data on baseline risk factors and lifestyle characteristics. MAIN OUTCOME MEASURES: 40-year total and cause-specific mortality through linkage to nation-wide death registers.
RESULTS: The study groups were practically identical at baseline in 1974, and the 5-year intervention significantly improved risk factors (body mass index, blood pressure, serum lipids and glucose), and total CVD risk by 46% in the intervention group. Despite this, total mortality has been consistently higher up to 25 years post-trial in the intervention group than the control group, and converging thereafter. Increased mortality risk was driven by CVD and accidental deaths. Of the newly-analysed baseline factors, there was a significant interaction for mortality between intervention group and yearly vacation time (P=0.027): shorter vacation was associated with excess 30-year mortality in the intervention (hazard ratio 1.37, 95% CI 1.03-1.83, P=0.03), but not in the control group (P=0.5). This finding was robust to multivariable adjustments.
CONCLUSION: After a multifactorial intervention for healthy men with at least one CVD risk factor, there has been an unexpectedly increased mortality in the intervention group. This increase was especially observed in a subgroup characterised by shorter vacation time at baseline. Although this adverse response to personal preventive measures in vulnerable individuals may be characteristic to men of high social status with subclinical CVD, it clearly deserves further investigation.

Entities:  

Keywords:  Multifactorial prevention; mortality; vacation

Mesh:

Substances:

Year:  2018        PMID: 30272088     DOI: 10.1007/s12603-018-1099-0

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  47 in total

1.  Worksite wellness programs for cardiovascular disease prevention: a policy statement from the American Heart Association.

Authors:  Mercedes Carnethon; Laurie P Whitsel; Barry A Franklin; Penny Kris-Etherton; Richard Milani; Charlotte A Pratt; Gregory R Wagner
Journal:  Circulation       Date:  2009-09-30       Impact factor: 29.690

2.  Stressed brain, stressed heart?

Authors:  Ilze Bot; Johan Kuiper
Journal:  Lancet       Date:  2017-01-12       Impact factor: 79.321

Review 3.  Stress and cardiovascular disease.

Authors:  Andrew Steptoe; Mika Kivimäki
Journal:  Nat Rev Cardiol       Date:  2012-04-03       Impact factor: 32.419

4.  Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.

Authors:  Rena R Wing; Paula Bolin; Frederick L Brancati; George A Bray; Jeanne M Clark; Mace Coday; Richard S Crow; Jeffrey M Curtis; Caitlin M Egan; Mark A Espeland; Mary Evans; John P Foreyt; Siran Ghazarian; Edward W Gregg; Barbara Harrison; Helen P Hazuda; James O Hill; Edward S Horton; Van S Hubbard; John M Jakicic; Robert W Jeffery; Karen C Johnson; Steven E Kahn; Abbas E Kitabchi; William C Knowler; Cora E Lewis; Barbara J Maschak-Carey; Maria G Montez; Anne Murillo; David M Nathan; Jennifer Patricio; Anne Peters; Xavier Pi-Sunyer; Henry Pownall; David Reboussin; Judith G Regensteiner; Amy D Rickman; Donna H Ryan; Monika Safford; Thomas A Wadden; Lynne E Wagenknecht; Delia S West; David F Williamson; Susan Z Yanovski
Journal:  N Engl J Med       Date:  2013-06-24       Impact factor: 91.245

Review 5.  Multiple risk factor interventions for primary prevention of coronary heart disease.

Authors:  Shah Ebrahim; Fiona Taylor; Kirsten Ward; Andrew Beswick; Margaret Burke; George Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

Review 6.  Mechanisms of stress in the brain.

Authors:  Bruce S McEwen; Nicole P Bowles; Jason D Gray; Matthew N Hill; Richard G Hunter; Ilia N Karatsoreos; Carla Nasca
Journal:  Nat Neurosci       Date:  2015-09-25       Impact factor: 24.884

7.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

8.  Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial.

Authors:  D Ornish; S E Brown; L W Scherwitz; J H Billings; W T Armstrong; T A Ports; S M McLanahan; R L Kirkeeide; R J Brand; K L Gould
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321

Review 9.  Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603,838 individuals.

Authors:  Mika Kivimäki; Markus Jokela; Solja T Nyberg; Archana Singh-Manoux; Eleonor I Fransson; Lars Alfredsson; Jakob B Bjorner; Marianne Borritz; Hermann Burr; Annalisa Casini; Els Clays; Dirk De Bacquer; Nico Dragano; Raimund Erbel; Goedele A Geuskens; Mark Hamer; Wendela E Hooftman; Irene L Houtman; Karl-Heinz Jöckel; France Kittel; Anders Knutsson; Markku Koskenvuo; Thorsten Lunau; Ida E H Madsen; Martin L Nielsen; Maria Nordin; Tuula Oksanen; Jan H Pejtersen; Jaana Pentti; Reiner Rugulies; Paula Salo; Martin J Shipley; Johannes Siegrist; Andrew Steptoe; Sakari B Suominen; Töres Theorell; Jussi Vahtera; Peter J M Westerholm; Hugo Westerlund; Dermot O'Reilly; Meena Kumari; G David Batty; Jane E Ferrie; Marianna Virtanen
Journal:  Lancet       Date:  2015-08-19       Impact factor: 79.321

10.  Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data.

Authors:  Mika Kivimäki; Solja T Nyberg; G David Batty; Eleonor I Fransson; Katriina Heikkilä; Lars Alfredsson; Jakob B Bjorner; Marianne Borritz; Hermann Burr; Annalisa Casini; Els Clays; Dirk De Bacquer; Nico Dragano; Jane E Ferrie; Goedele A Geuskens; Marcel Goldberg; Mark Hamer; Wendela E Hooftman; Irene L Houtman; Matti Joensuu; Markus Jokela; France Kittel; Anders Knutsson; Markku Koskenvuo; Aki Koskinen; Anne Kouvonen; Meena Kumari; Ida E H Madsen; Michael G Marmot; Martin L Nielsen; Maria Nordin; Tuula Oksanen; Jaana Pentti; Reiner Rugulies; Paula Salo; Johannes Siegrist; Archana Singh-Manoux; Sakari B Suominen; Ari Väänänen; Jussi Vahtera; Marianna Virtanen; Peter J M Westerholm; Hugo Westerlund; Marie Zins; Andrew Steptoe; Töres Theorell
Journal:  Lancet       Date:  2012-09-14       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.